Technology News and Research

RSS

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

Cancer Research Technology has announced an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the 'protein kinase C' superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.

22 Mar 2010

EmSense releases new EmBand 24 neuromarketing measurement device

EmSense Corporation, the company that created the first scalable electroencephalography brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

22 Mar 2010

BEMA Granisetron development program: BDSI announces positive meeting with FDA

BioDelivery Sciences International, Inc. announced the positive outcome of a meeting with the FDA on the development program for BEMA Granisetron, the company’s potential treatment for the prevention of nausea and vomiting associated with cancer therapy. FDA concurred with BDSI’s plans to pursue a development program based on clinical pharmacokinetic data for a 505(b)(2) New Drug Application.

22 Mar 2010

University of Maryland professor honored with the 2010 Stockholm Water Prize

Dr. Rita Colwell, distinguished Professor from the University of Maryland and John Hopkins University's Bloomberg School of Public Health in the United States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's pioneering research on the prevention of waterborne infectious diseases has helped protect the health and lives of millions.

22 Mar 2010

USAID, Coca-Cola announce additional joint investment of $12.7M in global partnership

Today, the U.S. Agency for International Development and The Coca-Cola Company announce an additional joint investment of US$12.7 million in their global partnership, the Water and Development Alliance.

22 Mar 2010

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

Health insurance reform legislation: Speaker Nancy Pelosi's remarks on the House floor

Speaker Nancy Pelosi spoke on the House floor tonight in support of historic health insurance reform legislation. The House passed the Senate version of health insurance reform legislation by a vote of 219 to 212. That bill now goes to the President for his signature into law. A second bill, to improve the Senate bill, passed by a vote of 220 to 211 and goes to the Senate. Below are the Speaker's remarks.

22 Mar 2010

StockPreacher.com releases investment report on A.P. Pharma

StockPreacher.com announces an investment report featuring A.P. Pharma Inc. (Nasdaq:APPA). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Mar 2010

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Arrowhead Research Corporation today announced that the clinical trial being conducted by majority-owned subsidiary, Calando Pharmaceuticals, Inc., has demonstrated systemic delivery of siRNA and the successful “silencing” of a widely recognized cancer gene via RNA interference (RNAi) in humans.

22 Mar 2010

iMDsoft's MetaVision suite of solutions to be distributed by Dominion in Spain

iMDsoft®, a global leader in hospital-wide clinical information systems, and Dominion, a leading provider of technology solutions in Spain and Latin America, have announced an agreement whereby Dominion will distribute iMDsoft's MetaVision® suite of solutions in Spain.

22 Mar 2010

Aston University scientists receive grants to develop new forms of drug delivery

Before you swallow a tablet, or put it into a glass of water to dissolve, do you ever stop and think about how it actually works in your body and how quickly and effectively it can deliver the drug to where it is needed?

22 Mar 2010

Lab on a Chip for research on oxygen impact on brain cells

A mini-laboratory that makes it possible, among other things, to study how brain cells in stroke patients are affected by lack of oxygen is being developed by a research team at Luleå University of Technology in Sweden. Lab on a Chip is what the scientists are calling their mini-lab, which is expected to facilitate studies of all sorts of biological cells and how they are affected by different medicines, chemical substances, etc.

22 Mar 2010

ILSI Biomed Israel 2010 international conference to be held in Tel Aviv

Set against the backdrop of the global market recovery and the recent proliferation of the life sciences field, this June’s ILSI Biomed Israel 2010 international conference will be attended by the most prominent figures in the biotechnology, pharma and medical device sectors.

22 Mar 2010

Tricking TB into suicidal self-poisoning

Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.

22 Mar 2010

Team Consulting to provide Oval Medical Technologies new funds in exchange for equity

Leading medical technology firm Team Consulting has joined the consortium of investors that is providing seed funding to Oval Medical Technologies, a developer of proprietary medical pre-filled syringes and autoinjectors.

22 Mar 2010

Nanotechnology weapons for cancer

US Researchers have come up with new nanoparticle robots that are essentially a tiny army that can travel in the blood till they reach the cancers and then tweak some important cancer causing genes that can cure the cancer.

22 Mar 2010

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).

22 Mar 2010

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

People with chronic illness often struggle to manage several prescribed drugs at a time. It's overwhelming when the vials, bottles and inhalers bulge from your medicine cabinet and you're confused about which drug is which, or when to take what.

20 Mar 2010

Portable ultrasound device to treat chronic joint pain from arthritis

In recent years, doctors have used ultrasound to effective treat joint pain from arthritis and other ailments without the use of drugs. The drawback to these treatments, however, is that they can only be administered in a doctor's office or clinic, since the ultrasound devices currently used are bulky and expensive.

20 Mar 2010

Dartmouth-Hitchcock Medical Center awarded ECRI Institute Health Devices Achievement Award

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, is pleased to report that Dartmouth-Hitchcock Medical Center (Lebanon, New Hampshire) has received the 4th Annual ECRI Institute Health Devices Achievement Award yesterday for an innovative patient monitoring project that uses its Masimo SET pulse oximetry and Masimo Patient SafetyNet remote monitoring and clinician notification system.

20 Mar 2010

Technology News and Research

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

EmSense releases new EmBand 24 neuromarketing measurement device

BEMA Granisetron development program: BDSI announces positive meeting with FDA

University of Maryland professor honored with the 2010 Stockholm Water Prize

USAID, Coca-Cola announce additional joint investment of $12.7M in global partnership

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Health insurance reform legislation: Speaker Nancy Pelosi's remarks on the House floor

StockPreacher.com releases investment report on A.P. Pharma

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

iMDsoft's MetaVision suite of solutions to be distributed by Dominion in Spain

Aston University scientists receive grants to develop new forms of drug delivery

Lab on a Chip for research on oxygen impact on brain cells

ILSI Biomed Israel 2010 international conference to be held in Tel Aviv

Tricking TB into suicidal self-poisoning

Team Consulting to provide Oval Medical Technologies new funds in exchange for equity

Nanotechnology weapons for cancer

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

Portable ultrasound device to treat chronic joint pain from arthritis

Dartmouth-Hitchcock Medical Center awarded ECRI Institute Health Devices Achievement Award

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News